Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

246 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors.
Yazici Y, Yazici H. Yazici Y, et al. Among authors: yazici h. Ann Rheum Dis. 2007 Jan;66(1):124-7. doi: 10.1136/ard.2006.055848. Epub 2006 Jul 10. Ann Rheum Dis. 2007. PMID: 16831828 Free PMC article.
Elderly-onset rheumatoid arthritis.
Yazici Y, Paget SA. Yazici Y, et al. Rheum Dis Clin North Am. 2000 Aug;26(3):517-26. doi: 10.1016/s0889-857x(05)70154-x. Rheum Dis Clin North Am. 2000. PMID: 10989510 Review.
Decreased flares of rheumatoid arthritis during the first year of etanercept treatment: further evidence of clinical effectiveness in the "real world".
Yazici Y, Erkan D, Kulman I, Belostocki K, Harrison MJ. Yazici Y, et al. Ann Rheum Dis. 2002 Jul;61(7):638-40. doi: 10.1136/ard.61.7.638. Ann Rheum Dis. 2002. PMID: 12079908 Free PMC article.
Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed?
Yazici Y, Erkan D. Yazici Y, et al. Ann Rheum Dis. 2004 May;63(5):607-8; author reply 608. Ann Rheum Dis. 2004. PMID: 15082503 Free PMC article. No abstract available.
Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities.
Yazici Y, Sokka T, Kautiainen H, Swearingen C, Kulman I, Pincus T. Yazici Y, et al. Ann Rheum Dis. 2005 Feb;64(2):207-11. doi: 10.1136/ard.2004.023408. Epub 2004 Jun 18. Ann Rheum Dis. 2005. PMID: 15208176 Free PMC article.
Inclusion criteria as widely used for rheumatoid arthritis clinical trials: patient eligibility in a Turkish cohort.
Gogus F, Yazici Y, Yazici H. Gogus F, et al. Among authors: yazici h, yazici y. Clin Exp Rheumatol. 2005 Sep-Oct;23(5):681-4. Clin Exp Rheumatol. 2005. PMID: 16173246
Biologics in development for rheumatoid arthritis: relevance to osteoarthritis.
Abramson SB, Yazici Y. Abramson SB, et al. Among authors: yazici y. Adv Drug Deliv Rev. 2006 May 20;58(2):212-25. doi: 10.1016/j.addr.2006.01.008. Epub 2006 Feb 28. Adv Drug Deliv Rev. 2006. PMID: 16567019 Review.
Prospects for disease modification in osteoarthritis.
Abramson SB, Attur M, Yazici Y. Abramson SB, et al. Among authors: yazici y. Nat Clin Pract Rheumatol. 2006 Jun;2(6):304-12. doi: 10.1038/ncprheum0193. Nat Clin Pract Rheumatol. 2006. PMID: 16932709 Review.
Monitoring outcomes of arthritis and longitudinal data collection using patient questionnaires in routine care.
Yazici Y. Yazici Y. Bull NYU Hosp Jt Dis. 2006;64(1-2):40-4. Bull NYU Hosp Jt Dis. 2006. PMID: 17121488 Review.
Differences in clinical status measures in different ethnic/racial groups with early rheumatoid arthritis: implications for interpretation of clinical trial data.
Yazici Y, Kautiainen H, Sokka T. Yazici Y, et al. J Rheumatol. 2007 Feb;34(2):311-5. J Rheumatol. 2007. PMID: 17304656
246 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback